Posted in | News | Bionanotechnology

Thermal Separation of Complex Polymers

The Postnova TF2000 is an advanced thermal field flow fractionation (TF3) system that provides a highly efficient method of separating and characterising complex polymer samples such as natural or synthetic rubbers, starches and paints from approximately 10 kDa up to 100 MDa and more in organic and aqueous solvents.

The TF2000 uses a temperature gradient as the driving force for its separation of polymers and particles. Molecules affected by the thermal gradient undergo diffusion which enables separation by both their molar mass and chemical composition. This unique feature allows the separation of different materials having the same molar mass. The separation can be further optimized by the use of different eluents and various temperature programs.

Drawing upon proprietary Postnova Analytics technology the TF2000 system is able to separate polymers and particles at the same time without the limitations associated with GPC/SEC. Unlike traditional GPC/SEC separation, no sample treatment is necessary with the Postnova TF2000 as samples can be injected without pre-filtration. This allows the characterization of complex polymer and nanoparticulate samples without any potential alteration and damage. Also beneficially the TF2000 has no size exclusion limit and therefore even ultra-high molar mass, branched and cross-linked polymers as well as gels, aggregates and particles can be separated using the system.

To enable users to fully realise the wide applications potential of the thermal field flow fractionation technique, the Postnova TF2000 system is available with various add-on modules and special FFF detectors including Refractive Index (RI), Multi-Angle Light Scattering (MALS) and Dynamic Light Scattering (DLS). All Postnova FFF modules and FFF detectors have been especially designed and optimized for FFF.

For further information please visit www.postnova.com/tf2000-overview.html or contact Postnova Analytics on +44-1885-475007 / [email protected].

Founded in 1997, Postnova Analytics is the inventor and leading international supplier of Field-Flow Fractionation (FFF) systems for markets including biopharmaceuticals, polymers, materials, nanotechnology and environmental sciences. Leveraging its unique and patented modular FFF - Light Scattering Platform, Postnova has been able to provide high performance solutions to a wide range of applications. Today the company's growing product portfolio includes Flow FFF, Centrifugal FFF, Thermal FFF, Size Exclusion Chromatography (SEC), MALS and DLS Light Scattering.  Postnova (www.postnova.com) is located and headquartered in Landsberg am Lech (Germany) and has subsidiaries in the USA, UK and Finland. These offices in conjunction with a highly qualified and trained distribution network provides informed local support to customers worldwide.


Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Postnova Analytics. (2019, February 11). Thermal Separation of Complex Polymers. AZoNano. Retrieved on April 28, 2024 from https://www.azonano.com/news.aspx?newsID=34862.

  • MLA

    Postnova Analytics. "Thermal Separation of Complex Polymers". AZoNano. 28 April 2024. <https://www.azonano.com/news.aspx?newsID=34862>.

  • Chicago

    Postnova Analytics. "Thermal Separation of Complex Polymers". AZoNano. https://www.azonano.com/news.aspx?newsID=34862. (accessed April 28, 2024).

  • Harvard

    Postnova Analytics. 2019. Thermal Separation of Complex Polymers. AZoNano, viewed 28 April 2024, https://www.azonano.com/news.aspx?newsID=34862.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.